Functions of the proteasome from protein degradation to disease therapy

Drugging the Undruggable: Targeted Protein Degradation as Medicine - 5 April 2022Подробнее

Prof. Benjamin Ebert: “Targeted protein degradation for the treatment of cancer.”Подробнее

Stewart Fisher - Dana-Farber Targeted Degradation Webinar SeriesПодробнее

Current and Future Directions for Novel Therapy for Multiple Myeloma: Paul G. Richardson, MDПодробнее

Katherine Donovan - Dana-Farber Targeted Degradation Webinar SeriesПодробнее

Benika Pinch and Seth Carbonneau - Dana-Farber Targeted Degradation Webinar SeriesПодробнее

Michael Rapé - Dana-Farber Targeted Degradation Webinar SeriesПодробнее

Georg Winter - Dana-Farber Targeted Degradation Webinar SeriesПодробнее

Paradigm Shift in Drug Discovery: Discover Small Molecule Degraders Using E3scan Technology PlatformПодробнее

Sara Buhrlage - Dana-Farber Targeted Degradation Webinar SeriesПодробнее

David Komander - Dana-Farber Targeted Degradation Webinar SeriesПодробнее

Jay Bradner - Dana-Farber Targeted Degradation Webinar SeriesПодробнее

Brenda Schulman - Dana-Farber Targeted Degradation Webinar SeriesПодробнее

Carolyn Bertozzi - Dana-Farber Targeted Degradation Webinar SeriesПодробнее

Biochemistry: Catabolism of Proteins & of Amino Acid NitrogenПодробнее

Immunoproteasome AnimationПодробнее

ULK2 essential for degradation of ubiquitinated protein aggregates & homeostasis in skeletal muscleПодробнее

Anne Bertolotti (MRC LMB) 3: A Platform to Identify Selective Protein Phosphatase InhibitorsПодробнее

Making the Problem Go Away: Induced Protein Degradation as a Novel Therapeutic StrategyПодробнее

Dr. Paul Richardson on novel approaches for treating multiple myeloma | Dana-Farber Cancer InstituteПодробнее